NANCY STEPANEK: Open Payments
NPI 1861624843 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 12 payments from 10 companies in 2025. Trend: 2023 $1,425 · 2024 $1,514 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $247 |
| Amgen Inc. | 1 | $129 |
| Averitas Pharma Inc. | 1 | $125 |
| Lundbeck LLC | 2 | $124 |
| Novo Nordisk Inc | 1 | $112 |
| Medtronic, Inc. | 1 | $108 |
| Edwards Lifesciences Corporation | 1 | $108 |
| Otsuka America Pharmaceutical, Inc. | 1 | $107 |
| Abbott Laboratories | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: REXULTI, TEZSPIRE, QUTENZA, UZEDY, AUSTEDO XR, Ozempic, PULSESELECT, SAPIEN 3 Ultra RESILIA.
Industry payments across MO — which companies pay providers there.
